YC-1 inhibits proliferation of breast cancer cells by downregulating EZH2 expression via activation of c-Cbl and ERK

CMUR > College of Pharmacy > Graduate Institute of Pharmaceutical Chemistry > Journal articles > Item 310903500/53754

Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/53754

Title:	YC-1 inhibits proliferation of breast cancer cells by downregulating EZH2 expression via activation of c-Cbl and ERK
Authors:	(Ling-Chu Chang);(Hui-Yi Lin);(Meng-Tung Tsai);鄒瑞煌(Ruey-Hwang Chou);(Fang-Yu Lee);(Che-Ming Teng);謝閔凔(Min-Tsang Hsieh);洪欣儀(Hsin-Yi Hung);黃麗嬌(Li-Jiau Huang);余永倫(Yung-Luen Yu);郭盛助(Sheng-Chu Kuo)
Contributors:	藥學院藥物化學研究所;中國附醫醫學研究部
Keywords:	YC-1;triple-negative breast cancer;EZH2;c-Cbl;ERK
Date:	2014-09
Issue Date:	2014-12-23 16:23:49 (UTC+8)
Relation:	BRITISH JOURNAL OF PHARMACOLOGY 171(17):4010-4025
Appears in Collections:	[Graduate Institute of Pharmaceutical Chemistry] Journal articles

Files in This Item:

There are no files associated with this item.